Remogliflozin

A potent sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor



BV-B2082-1	1 mg	105.00 USD

BV-B2082-5	5 mg	413.00 USD

Remogliflozin is a potent sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor with antihyperglycemic activity. Potential drug for treatment of type 2 diabetes.

PRODUCT PROPERTIES
Formula:		C₂₃H₃₄N₂O₇
MW:		450.53
CAS:		329045-45-6
Purity:		≥98% by HPLC
Appearance:		White solid.
Solubility:		DMSO (>40 mg/ml)
Long Term Storage:		-20°C
Background / Technical Information:		For the Original Manufacturer's data sheet please click here.

TECHNICAL DOCUMENTS Print as PDF	RELATED PRODUCTS No related products available
PRODUCT SUPPORT Technical Service Bulk Quantity Quote Customer Service	CATALOG SECTION

Remogliflozin

TECHNICAL DOCUMENTS

RELATED PRODUCTS

PRODUCT SUPPORT

CATALOG SECTION